Eventide Asset Management LLC Trims Stake in Collegium Pharmaceutical, Inc.
Eventide Asset Management LLC has reduced its position in Collegium Pharmaceutical, Inc. (COLL), though it maintains a significant remaining stake valued at $83.65 million. This institutional shift comes as Collegium continues to integrate recent acquisitions and navigate the complex regulatory landscape of the specialty pain management market.